Close Menu

lymphoma

This is the second vaccine-development partnership struck between Advaxis and City of Hope in as many years, further cementing an ongoing and mutually beneficial research partnership between the company and the cancer research center, according to an Advaxis executive.

LLS will select ten small molecule candidates deemed to have the best chance of quickly advancing to clinical trials from its portfolio of grant-funded academic research projects, and Forma will use its computational solvent mapping technology to ready the molecules for the clinic.

The plant is designed to accommodate Genentech's needs and those of its partner-turned-acquirer, Roche. The facility's packaging lines are now being validated, which is required for Genentech to begin making and shipping drugs.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.